Sun Pharmaceutical and Zydus Lifesciences shares could see pressure on Monday as both companies have issued limited recall for some pharmaceutical products in the US market.

Zydus Lifesciences (ZYDUSLIF) has shown resilience in the face of recent stock price corrections and rising competition in the U.S. generics market.

Zydus Lifesciences Share Price could see significant upside move as Sharekhan Research has suggested BUY Call considering strong fundamentals of the company.

Market expert Varun Dubey has suggested four BUY Calls and no SELL Call for short term investors and traders.

Market analyst and Derivatives expert Rajesh Palviya from Axis Securities, has suggested three BUY Calls and no SELL Call for today’s trading session.

Market expert Arman Nahar has suggested four BUY Calls and no SELL Call for today’s trading session.